Trident Lifeline Ltd Stock Price Today (NSE: TLL)
Fundamental Score
Trident Lifeline Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Trident Lifeline Ltd share price today is ₹262.85, up +0.00% on NSE/BSE as of 20 February 2026. Trident Lifeline Ltd (TLL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹350.60 (Cr). The 52-week high for TLL share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 22.96x, TLL is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 20.02% and a debt-to-equity ratio of 0.73.
Trident Lifeline Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Trident Lifeline Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Trident Lifeline Share Price: A Financial Analysis
The pharmaceutical industry, typically resistant to economic downturns due to consistent healthcare demand, is currently experiencing increased pricing pressure and scrutiny over drug development costs. In this context, understanding the financial health of individual companies becomes critical. This analysis examines the Trident Lifeline share price, currently at ₹296.3999938964844, utilizing key financial metrics and peer comparisons. Our examination is part of a larger, 80-parameter fundamental audit verified by Sweta Mishra. The aim is to provide an objective overview, not to offer any buy/sell recommendations.
Trident Lifeline Ltd's Price-to-Earnings (PE) ratio stands at 22.96. This valuation should be considered within the context of its peers. Considering
Mankind Pharma Ltd, one might analyze differences in management quality that justify potentially different PE ratios. A detailed qualitative analysis comparing management efficiency, strategic decision-making, and investor communication strategies is crucial for making such comparisons.A critical aspect of Trident Lifeline's financial standing is its Return on Capital Employed (ROCE) of 18.12%. This indicates the efficiency with which the company generates profits from its invested capital. A consistently high ROCE, such as this, suggests a widening economic moat. It means the company has competitive advantages like strong brand recognition, cost efficiencies, or proprietary technology, making it difficult for competitors to erode its profitability. A higher ROCE relative to peers could suggest a stronger competitive positioning in the long run.
Further detailed analysis, beyond just these figures, is crucial. Factors such as debt levels, cash flow generation, and future growth prospects should be evaluated alongside comparative industry performance and peer reviews such as those of Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd, to gain a comprehensive understanding of Trident Lifeline's intrinsic value and potential drivers affecting its share price.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Trident Lifeline Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TLL across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (20.02%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (18.12%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 22.96 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (48.61%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (82.43%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Interest Coverage (5.03x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (63.10%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
2 factors identified
Limited Institutional Interest (FII+DII: 8.12%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Trident Lifeline Ltd Financial Statements
Comprehensive financial data for Trident Lifeline Ltd including income statement, balance sheet and cash flow
About TLL (Trident Lifeline Ltd)
Trident Lifeline Ltd (TLL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹350.60 (Cr). Trident Lifeline Ltd has delivered a Return on Equity (ROE) of 20.02% and a ROCE of 18.12%. The debt-to-equity ratio stands at 0.73, reflecting the company's capital structure. Investors tracking TLL share price can monitor key metrics including P/E ratio, promoter holding of 63.10%, and quarterly earnings growth.
Company Details
Key Leadership
Latest News
TLL Share Price: Frequently Asked Questions
What is the current share price of Trident Lifeline Ltd (TLL)?
As of 20 Feb 2026, 02:52 pm IST, Trident Lifeline Ltd share price is ₹262.85. The TLL stock has a market capitalisation of ₹350.60 (Cr) on NSE/BSE.
Is TLL share price Overvalued or Undervalued?
TLL share price is currently trading at a P/E ratio of 22.96x, compared to the industry average of 31.77x. Based on this relative valuation, the Trident Lifeline Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of TLL share price?
The 52-week high of TLL share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Trident Lifeline Ltd share price?
Key factors influencing TLL share price include quarterly earnings growth (Sales Growth: 82.43%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Trident Lifeline Ltd a good stock for long-term investment?
Trident Lifeline Ltd shows a 5-year Profit Growth of N/A% and an ROE of 20.02%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.73 before investing in TLL shares.
How does Trident Lifeline Ltd compare with its industry peers?
Trident Lifeline Ltd competes with major peers in the Pharmaceuticals. Investors should compare TLL share price P/E of 22.96x and ROE of 20.02% against the industry averages to determine competitive standing.
What is the P/E ratio of TLL and what does it mean?
TLL share price has a P/E ratio of 22.96x compared to the industry average of 31.77x. Investors pay ₹23 for every ₹1 of annual earnings.
How is TLL performing according to Bull Run's analysis?
TLL has a Bull Run fundamental score of 43.3/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does TLL belong to?
TLL operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Trident Lifeline Ltd share price.
What is Return on Equity (ROE) and why is it important for TLL?
TLL has an ROE of 20.02%, which indicates excellent management efficiency. ROE measures how efficiently Trident Lifeline Ltd generates profits from shareholders capital.
How is TLL debt-to-equity ratio and what does it indicate?
TLL has a debt-to-equity ratio of 0.73, which indicates moderate leverage that should be monitored.
What is TLL dividend yield and is it a good dividend stock?
TLL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Trident Lifeline Ltd shares.
How has TLL share price grown over the past 5 years?
TLL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in TLL and why does it matter?
Promoters hold 63.10% of TLL shares, with 3.43% pledged. High promoter holding often indicates strong management confidence in Trident Lifeline Ltd.
What is TLL market capitalisation category?
TLL has a market capitalisation of ₹351 crores, placing it in the Small-cap category.
How volatile is TLL stock?
TLL has a beta of N/A. A beta > 1 suggests the Trident Lifeline Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is TLL operating profit margin trend?
TLL has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is TLL quarterly performance?
Recent quarterly performance shows Trident Lifeline Ltd YoY Sales Growth of 82.43% and YoY Profit Growth of 48.61%.
What is the institutional holding pattern in TLL?
TLL has FII holding of 7.71% and DII holding of 0.41%. Significant institutional holding often suggests professional confidence in the Trident Lifeline Ltd stock.